Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income (loss)	$ 16,559,619	$ 7,026,026
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	24,741	55,737
Other-than-temporary impairments	(0)	393,455
Realized investment gains (losses), net	(6,759,716)	(4,560,282)
Change in fair value of equity securities	(14,462,029)	(10,994,305)
Unrealized trading (gains) losses included in income	0	(1,329)
Realized trading (gains) losses included in income	13,283	(20,360)
Amortization of cost of insurance acquired	516,261	536,228
Depreciation and depletion	1,635,706	1,862,637
Stock-based compensation	486,797	170,538
Charges for mortality and administration of universal life and annuity products	(4,480,817)	(4,791,098)
Interest credited to account balances	2,831,885	2,940,521
Change in accrued investment income	31,527	299,159
Change in reinsurance receivables	827,435	(171,403)
Change in policy liabilities and accruals	(3,074,992)	(3,774,549)
Change in income taxes receivable (payable)	1,378,658	(1,433,348)
Change in other assets and liabilities, net	4,194,376	2,240,191
Net cash used in operating activities	(277,266)	(10,222,182)
Proceeds from investments sold and matured:
Fixed maturities available for sale	8,628,136	18,581,107
Equity securities	10,735,510	5,306,206
Trading securities	17,983	29,283
Mortgage loans	1,443,119	7,758,199
Real estate	11,387,025	5,973,637
Notes receivable	3,984,614	1,372,154
Policy loans	903,696	1,588,854
Total proceeds from investments sold and matured	37,100,083	40,609,440
Cost of investments acquired:
Fixed maturities available for sale	(1,112,505)	(20,000)
Equity securities	(12,540,638)	(26,353,197)
Trading securities	(32,382)	(16,133)
Mortgage loans	(1,755,496)	(3,305,354)
Real estate	(4,236,603)	(5,507,777)
Notes receivable	(5,870,657)	(7,840,000)
Policy loans	(728,348)	(838,053)
Total cost of investments acquired	(26,276,629)	(43,880,514)
Net cash provided by (used in) investing activities	10,823,454	(3,271,074)
Cash flows from financing activities:
Policyholder contract deposits	3,455,489	3,303,536
Policyholder contract withdrawals	(3,400,630)	(4,327,607)
Proceeds from notes payable/line of credit	19,500,000	0
Payments of principal on notes payable/line of credit	(35,500,000)	0
Purchase of treasury stock	(605,230)	(394,712)
Non controlling contributions (distributions) of consolidated subsidiary	0	0
Net cash used in financing activities	(16,550,371)	(1,418,783)
Net increase (decrease) in cash and cash equivalents	(6,004,183)	(14,912,039)
Cash and cash equivalents at beginning of period	30,787,278	39,025,754
Cash and cash equivalents at end of period	$ 24,783,095	$ 24,113,715